107 related articles for article (PubMed ID: 8322482)
1. Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization.
Hildreth SW; Baggs RR; Brownstein DG; Castleman WL; Paradiso PR
Vaccine; 1993; 11(6):615-8. PubMed ID: 8322482
[TBL] [Abstract][Full Text] [Related]
2. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.
Murphy BR; Sotnikov AV; Lawrence LA; Banks SM; Prince GA
Vaccine; 1990 Oct; 8(5):497-502. PubMed ID: 2251875
[TBL] [Abstract][Full Text] [Related]
3. Immunogen-induced enhanced pulmonary histopathology in the RSV cotton rat model.
Hildreth SW; Baggs RR; Brownstein DG; Castleman WL; Paradiso PR
Vaccine; 1993; 11(6):689-90. PubMed ID: 8322496
[No Abstract] [Full Text] [Related]
4. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.
Connors M; Collins PL; Firestone CY; Sotnikov AV; Waitze A; Davis AR; Hung PP; Chanock RM; Murphy BR
Vaccine; 1992; 10(7):475-84. PubMed ID: 1609551
[TBL] [Abstract][Full Text] [Related]
5. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
[TBL] [Abstract][Full Text] [Related]
6. Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV.
Murphy BR; Prince GA; Lawrence LA; Croen KD; Collins PL
Virus Res; 1990 Jun; 16(2):153-62. PubMed ID: 2385958
[TBL] [Abstract][Full Text] [Related]
7. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice.
Vaux-Peretz F; Chapsal JM; Meignier B
Vaccine; 1992; 10(2):113-8. PubMed ID: 1539464
[TBL] [Abstract][Full Text] [Related]
9. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine.
Kakuk TJ; Soike K; Brideau RJ; Zaya RM; Cole SL; Zhang JY; Roberts ED; Wells PA; Wathen MW
J Infect Dis; 1993 Mar; 167(3):553-61. PubMed ID: 8440926
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge.
Wathen MW; Kakuk TJ; Brideau RJ; Hausknecht EC; Cole SL; Zaya RM
J Infect Dis; 1991 Mar; 163(3):477-82. PubMed ID: 1995720
[TBL] [Abstract][Full Text] [Related]
11. Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).
Murphy BR; Prince GA; Collins PL; Hildreth SW; Paradiso PR
Vaccine; 1991 Mar; 9(3):185-9. PubMed ID: 2042390
[TBL] [Abstract][Full Text] [Related]
12. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
Piedra PA; Wyde PR; Castleman WL; Ambrose MW; Jewell AM; Speelman DJ; Hildreth SW
Vaccine; 1993 Nov; 11(14):1415-23. PubMed ID: 7508665
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
[TBL] [Abstract][Full Text] [Related]
14. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.
Murphy BR; Prince GA; Walsh EE; Kim HW; Parrott RH; Hemming VG; Rodriguez WJ; Chanock RM
J Clin Microbiol; 1986 Aug; 24(2):197-202. PubMed ID: 3755730
[TBL] [Abstract][Full Text] [Related]
16. Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus.
Sawada A; Nakayama T
Microbiol Immunol; 2016 Apr; 60(4):234-42. PubMed ID: 26865035
[TBL] [Abstract][Full Text] [Related]
17. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.
Murphy BR; Walsh EE
J Clin Microbiol; 1988 Aug; 26(8):1595-7. PubMed ID: 2459154
[TBL] [Abstract][Full Text] [Related]
18. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
19. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T
Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725
[TBL] [Abstract][Full Text] [Related]
20. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
